The Psychiatry Division of QPS specializes in psychiatric pharmaceutical research. We pride ourselves on accuracy, ethics, and quality data, as well as interrater reliability and traditionally low placebo responses.
Our large patient database, in addition to our in-house advertising agency enables QPS to be consistently in the top 20% of nationwide enrollers. We use a central IRB to ensure full regulatory compliance. Our full time quality assurance team, regulatory department, rigorous standard operating procedures and experienced staff of study coordinators consistently provide quality results.
Under Medical Directors Gustavo Rey, PsyD, a Board Certified Psychologist and Dr. Rafael Rivas-Vazquez, the Psychiatry Division of QPS has been conducting top-quality clinical research for over 10 years, and published papers in nationally recognized journals as well as providing safety and efficacy data for various investigational products.
SPECIALTY AREAS OF FOCUS
We specialize in investigating:
- Adult ADHD
- Anxiety
- Bipolar Disorder
- Child ADHD
- Depression
- Geriatric Psychiatry
- Headaches
- Insomnia
- Migraines
- Pediatric Insomnia
- Pediatric Depression
- Schizophrenia
ASSESSMENT CAPABILITIES
Experienced Raters in the following scales:
- ADHD-RS
- BCME
- Conner’s Patient Rating Scale
- HAM A
- HAM D
GUSTAVO REY, PSYD
Gustavo Rey, PsyD is a Board Certified Psychologist with extensive experience in clinical research, having been published over 70 times in national journals and having conducted over 95 psychology-related studies at QPS. Dr. Rey received his PhD and Master’s Degree in Clinical Neuropsychology from the University of Houston. In addition to his work at QPS, Dr. Rey is currently on the staff of five local hospitals, serves as an Adjunct Associate Professor of Psychology at the University of Miami, and is the Director of Neuropsychology at Miami Children’s Hospital.
